Migraine sufferers have a new ally in their fight against debilitating headaches. Anti-CGRP monoclonal antibodies are becoming a go-to choice for preventing migraines. These drugs work by targeting a specific pathway in the body involved in migraine attacks. But how well do patients stick with these
Senecavirus A (SVA) has been a major headache for the swine industry, causing big problems and losses worldwide. To tackle this, scientists have been working on virus-neutralizing monoclonal antibodies (NAbs). These NAbs are like tiny soldiers that can help us understand how the virus interacts with
Scientists are always looking for better ways to make medicines last longer and work better. One big challenge is keeping proteins, like those in some drugs, stable when they are dried out. Trehalose is a sugar that is often used to help protect these proteins. But there's a problem: trehalose can c
Two new drugs, lecanemab and donanemab, have hit the market. They are designed to tackle Alzheimer's disease. They work by targeting and removing beta-amyloid protein from the brain. This protein is a key player in the development of Alzheimer's. The drugs have shown some promising results in cl
Collagens are everywhere, from mammals to marine life like jellyfish. And we're talking about jellyfish collagen here, which is becoming quite popular due to its skin healing and immune boosting benefits. Scientists wanted to create tools to detect this special collagen, so they made four monoclonal
Imagine this: you’re running downhill, muscles working hard, and you wonder if this rigorous exercise could help boost proteins that fight cancer. That’s exactly what scientists set out to test. They looked at a protein called C1q, which helps activate the body’s immune response against cancer cells
